$CGTX 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Other Events Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
06 Aug 2026	8-K: Results of Operations and Financial Condition
24 Jun 2026	8-K: Other Events
18 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
04 Jun 2026	8-K: Regulation FD Disclosure
21 May 2026	8-K: Other Events
07 May 2026	8-K: Results of Operations and Financial Condition
26 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
02 Mar 2026	8-K: Other Events
27 Jan 2026	8-K: Other Events
18 Dec 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
06 Nov 2025	8-K: Results of Operations and Financial Condition
15 Sep 2025	8-K: Other Events
28 Aug 2025	8-K: Entry into a Material Definitive Agreement
26 Aug 2025	8-K: Other Events
07 Aug 2025	8-K: Results of Operations and Financial Condition
20 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2025	8-K: Other Events
02 Jun 2025	8-K: Other Events
08 May 2025	8-K: Other Events

Comments